NRC Health filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 4, 2026, reporting condensed consolidated financial data including total assets of $139.213 million and a shift to negative shareholders' equity.
Key Highlights
- Total assets: According to the filing, NRC Health reported total assets of $139.213 million as of September 30, 2026, up from $134.878 million at December 31, 2025.
- Shareholders' equity turned negative: Total shareholders' equity was $(9.122) million as of September 30, 2026, compared to $13.990 million at December 31, 2025.
- Notes payable increased: Long-term notes payable, net of current portion and unamortized debt issuance costs, rose to $98.133 million from $75.021 million at year-end 2025.
- Accumulated deficit widened: The company reported an accumulated deficit of $(23.209) million as of September 30, 2026, versus $(17.298) million at December 31, 2025.
- Shares outstanding: Common shares outstanding were 21,221,538 as of October 31, 2026, with treasury stock totaling 10,625,111 shares.
- Trade accounts receivable: Trade accounts receivable increased to $15.341 million from $11.108 million at December 31, 2025, net of an allowance for credit losses of $80 thousand in both periods.
- Deferred revenue: Deferred revenue rose to $20.277 million from $16.201 million at December 31, 2025.
NRC Health Balance Sheet Shows Rising Debt and Negative Equity in Q3 2026
NRC Health (NASDAQ:NRC), a Delaware-incorporated company headquartered at 1245 Q Street, Lincoln, Nebraska, filed its quarterly report covering the period ended September 30, 2026. According to the filing, total assets grew to $139.213 million from $134.878 million at the end of fiscal year 2025, driven in part by an increase in trade accounts receivable and deferred contract costs, the latter rising to $3.581 million from $2.498 million.
The filing disclosed that total liabilities increased significantly to $148.335 million from $120.888 million at December 31, 2025. The primary driver was a rise in long-term notes payable, net of current portion and unamortized debt issuance costs, to $98.133 million from $75.021 million. Combined with a current portion of notes payable of $4.767 million, total debt-related obligations grew materially over the period. As a result of this liability growth, total shareholders' equity moved to $(9.122) million from a positive $13.990 million at year-end 2025.
The company's accumulated deficit widened to $(23.209) million from $(17.298) million, while treasury stock at cost increased to $(178.809) million from $(152.624) million, reflecting an increase in treasury shares from 9,329,252 to 10,625,111. Additional paid-in capital stood at $192.864 million versus $183.880 million. The filing notes that it contains forward-looking statements, which the company states are subject to certain risks and uncertainties, and cautions readers not to place undue reliance on them.
What Was Disclosed
NRC Health's 10-Q for the quarter ended September 30, 2026 disclosed condensed consolidated balance sheet data showing asset growth, a substantial increase in long-term debt, a widened accumulated deficit, and a shift to negative total shareholders' equity compared to December 31, 2025.



Please wait processing your request...